How many investments has Toronto Innovation Acceleration Partners made?

Toronto Innovation Acceleration Partners has 45 tracked investments.

What stage does Toronto Innovation Acceleration Partners invest at?

Toronto Innovation Acceleration Partners invests at the Pre-Seed, Seed stages.

What sectors does Toronto Innovation Acceleration Partners focus on?

Toronto Innovation Acceleration Partners focuses on Biotech, Digital Health, Healthtech, Medical Devices.

Where is Toronto Innovation Acceleration Partners located?

Toronto Innovation Acceleration Partners is headquartered in Toronto, CA.

Who does Toronto Innovation Acceleration Partners co-invest with?

Toronto Innovation Acceleration Partners most often shares deals with Lumira Ventures, FACIT (Fight Against Cancer Innovation Trust), Stand Up Ventures, among 36 tracked co-investors.

Toronto Innovation Acceleration Partners

Venture studio

Toronto · Pre-Seed–Seed · 11 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into Toronto Innovation Acceleration Partners

1,259 people in our graph share verified history with the Toronto Innovation Acceleration Partners team — schools, employers, funds. One of them is your warm intro.

Achintya Chaudhariunlockedknows Mobeen Lalani · together at Scotiabank (overlapped)

knows the team · via CIBC

×2knows the team · via University of Toronto

×2knows the team · via Bar-Ilan University

×2knows the team · via York University

knows the team · via University of Ottawa

✨ Fox Verdict

Investment thesis

TIAP focuses on venture building of early-stage health science technologies emerging from its academic member institutions. It transforms early-stage scientific innovations into business ventures, de-risks ideas through expert financial and scientific advice, invests in early-stage innovations, and sources external venture capital for future funding. TIAP leverages a global and local network to connect industry, researchers, investors and members. It offers cornerstone programs and management support including LAB150-NextGen, UTEST, Venture Builder, Critical Technologies and Portfolio Management to advance inventions toward a market-ready state.

Invests inBiotech Digital Health Healthtech Medical Devices Canada Toronto

Source: firm website, verified Aug 3, 2026.

Stage

Pre-Seed–Seed

Toronto, CA

Instruments

Equity

Founded

2008

Tracked investments

Team · 11 people

from the firm's website

Barry Gee· Director, Public Affairs· Vancouver, British Columbia, Canadain

Barry Gee has more than 20 years of experience in strategic communications and stakeholder relations, primarily with Canadian health and life science organizations. He spent over a decade on the executive team at adMare BioInnovations and its predecessor, the Centre for Drug Research and Development (CDRD), serving as Senior Director of Communications and External Relations, and previously held roles at LifeSciences British Columbia, Innovate BC, and the federal Pacific Forest Research Centre. He holds a B.A. in Creative Writing from the University of Victoria.

b•••@tiap.careveal

Chris Adams· Part-time CFO· Toronto, Ontario, Canadain

Chris Adams is a CPA/CA with more than thirty years of experience who has provided bookkeeping, accounting, financial reporting, SR&ED, and corporate tax compliance services to early-stage technology companies and nonprofits since 2006. As part-time CFO at TIAP, he oversees accounting functions and both internal and external financial reporting. He holds a Bachelor of Commerce from the University of Toronto and earned his accounting designation while training at KPMG.

Diana Resetca· Analyst, Technology and Venture Development· Cologne, North Rhine-Westphalia, Germanyin

Diana Resetca joined TIAP in 2020 as an Analyst, Technology and Venture Development, supporting technology commercialization efforts and the LAB150 program. Working with the Life Sciences team and researchers at member institutions, she conducts scientific due diligence, market research, and competitive analysis to assess venture projects. She previously worked with local AI and biotechnology startups and nonprofits as an analyst and scientific consultant, holds an MSc in Chemistry from York University and a BSc in Biology and Chemistry from the University of Toronto, and has published research in journals including Nature Structural and Molecular Biology and Molecular Cell.

d•••@tiap.careveal

Dr. Angela Zhou· Analyst, Technology & Venture Development

Angela Zhou joined TIAP after working on two University of Toronto strategic initiatives, Medicine by Design and the Precision Medicine Initiative (PRiME), where she developed and managed funding and training programs connecting scientists, engineers, and clinicians in regenerative and precision medicine. She previously consulted for Turnstone Biologics on technical and regulatory writing and pre-clinical research support, and has served as Managing Editor of RCIScience and co-chaired the Canadian Science Policy Centre's Program Committee. She holds a PhD in Immunology and a BSc in Physiology and Immunology, both from the University of Toronto.

Dr. Phil Goldbach· Director, Technology and Venture Development

Phil Goldbach manages intellectual property across TIAP's (formerly MaRS Innovation) portfolio, advising on IP protection, patentability, and patent application filings, and he also manages projects in the Life Sciences portfolio while conducting technical and market due diligence on new technologies. Before TIAP, he trained at an intellectual property boutique law firm in Toronto within its life sciences patent practice and served as director of intellectual property for a Mississauga biotechnology startup focused on antibody-based products for animal health and food safety. He holds a PhD in Molecular Genetics from the University of Toronto and a JD from Osgoode Hall Law School.

Dr. Sohaib Siddiqui· Director, Technology & Venture Development· Aachen-Mitte, North Rhine-Westphalia, Germanyin

Sohaib Siddiqui provides medical, scientific, and business support to early-stage startups at TIAP, working with academic and institutional partners to identify medical technologies in digital health and medical devices. Before TIAP, he managed healthcare strategy at Kettlebeck Ventures, a family-office backed healthcare fund, and trained as a medical doctor and pediatric clinical researcher. He also holds an Innovation Fellow appointment at Women's College Hospital and earned degrees from Queen's University, the Royal College of Surgeons in Ireland, and a digital health certificate from Harvard Medical School.

Ido Kaminsky· Director, Technology and Venture Development· Vaughan, Ontario, Canadain

Ido Kaminsky was previously Director of Business Analysis at FutuRx, a biotech incubator backed by JJDC (J&J), Takeda Ventures, and Orbimed Israel, where he handled scouting, deal flow, scientific and business analysis, IP licensing, and venture formation, contributing to the launch of more than 10 biotechnology startups. He earlier worked at RM Global Partners, a boutique investment bank in the pharma, biotech, and medical-device sectors, and as an analyst at the Frankel Group, a life-science strategic consulting firm. He holds an M.Sc. in biochemistry from the Weizmann Institute of Science.

i•••@tiap.careveal

Michelle Kirkwood· Senior Director and HR Business Partner· Ajax, Ontario, Canadain

Michelle Kirkwood is an HR leader with experience in the financial and health care sectors, focused on organizational design and large-scale change management initiatives. She joined UHN in November 2020 and serves as the People & Culture partner for the Corporate Portfolio, UHN Retention Strategy, and UHN partner organizations, including acting as HR strategic partner to TIAP's CEO and team. She is a change management practitioner and participates on a burnout committee supporting interventions at Princess Margaret Hospital and the Peter Munk Cardiac Centre.

Mobeen Lalani· Manager, Technology and Venture Development; Co-Director, University of Toronto Early-Stage Technology (UTEST) program· Ontarioin

Mobeen Lalani manages technology and venture development at TIAP and co-directs the University of Toronto Early-Stage Technology (UTEST) program, where he works on identifying and commercializing health technologies, leading due diligence, market analysis, and technology development planning. He previously held sales and business development leadership roles at a telehealth startup and worked on healthcare innovation and strategy for a large Canadian pharmacy retailer, as well as health data transformation in primary care. He holds a Master of Health Informatics and a Bachelor of Science in Molecular Biology and Population Health from the University of Toronto and a certificate in Health Law and AI in Healthcare from the University of Ottawa.

m•••@tiap.careveal

Prakash Gowd· Vice President; Interim President & CEO· Greater Toronto Area, Canadain

Prakash Gowd joined TIAP in January 2024 as Vice President and became Interim President & CEO in April 2026. He has over 25 years of experience across biopharma, capital markets, and entrepreneurship, previously serving as COO and Head of Corporate Development at a mental health and psychedelic medicine company and as co-founder of a health technology company, both of which he helped take through public listing or acquisition. Earlier in his career he held biotech equity research and investment banking roles at CIBC World Markets, National Bank Financial, and Canaccord Capital, and he holds an MBA from McGill University plus Pharmacy and Zoology degrees from the University of British Columbia.

p•••@tiap.careveal

Susanne Staer· Corporate Secretary· Toronto, Ontario, Canadain

Susanne Staer is the Corporate Secretary at Toronto Innovation Acceleration Partners (TIAP), responsible for the organization's governance framework, board administration, annual general meetings, and record keeping. She also handles executive office administration and oversees marketing, external communications, social media, and website development. Before TIAP, she supported senior partners at a national law firm in mergers and acquisitions, corporate finance and securities, and previously worked in the Danish diplomatic corps with postings at Royal Danish Embassies in Russia and Ghana.

s•••@tiap.careveal

What they invest in

from 37 of 45 portfolio companies

Healthtech ×18Biotech ×17Medical Devices ×17AI & Machine Learning ×13Digital Health ×13Deep Tech ×11SaaS ×7Enterprise Software ×4

HQs:Canada×21Nigeria×1United States×1

Who they back

founder profiles across 21 portfolio companies

57%

solo founders

12 of 21 mapped founding teams

26%

repeat founders

of 19 founders with career history

Founding team size:solo founder×122 founders×63 founders×24+ founders×1

Where their founders studiedfrom 20 founders with education data

University of Toronto ×12Western University ×4

12 founders hold a PhD · 2 hold an MBA (of 21 with degree data)

Investments · 45 tracked

founders shown can be your intro path

By year:2024 · 1 2018 · 12 dated

7D Surgical7dsurgical.com inSep 2018

7D Surgical develops image-guided surgical navigation systems using machine-vision technology for spine, cranial, and percutaneous procedures.

AI & Machine LearningHealthtechMedical Devices

STEPHEN MARTIN(Executive Officer)MICHAEL CADOTTE(Director)VICTOR YOUNG(Executive Officer, Director)ADRIAN LINUS DINESH MARIAMPILLAI(Executive Officer, Director)MICHAEL APKON(Director)BEAU STANDISH(Executive Officer, Director)

Amacatheraamacathera.ca in

AmacaThera is a biotech company developing a tunable injectable hydrogel drug-delivery platform, based on hyaluronic acid and methylcellulose, for localized and long-acting release of therapeutics such as small molecules, biologics, peptides, and cells.

BiotechDigital HealthMedical DevicesToronto, CA

Mike Cooke(Co-Founder & CEO)inMolly Shoichet(Co-Founder & Chief Science Officer)

Co-investorsLumira Ventures Stand Up Ventures

Ardrabioardrabio.com in

Ardra uses fermentation technology to produce natural ingredients for food, perfumery, and cosmetics from renewable substrates, offering stable pricing and consistent quality independent of seasonal or geopolitical disruptions.

BiotechCleantechFoodTechNew MaterialsToronto, CA

Bitnobibitnobi.com in 𝕏

Bitnobi develops a patented system for secure sharing of large datasets across diverse data infrastructure and users.

Cloud ComputingCybersecurityData & InfrastructureEnterprise SoftwareToronto, CA

Blue Jbluej.com in 𝕏

Blue J is an AI-powered platform providing tax research and analysis tools for tax professionals and accountants across North America and the UK.

AI & Machine LearningLegalTechSaaSToronto, CA

Benjamin Alarie(CEO)inAlbert Yoon(Co-founder)Anthony Niblett(Co-founder)in

Co-investorsOak HC/FT Sapphire Ventures Creative Destruction Lab (CDL)Intrepid Growth Partners Mistral Venture Partners Relay Ventures

Bluedotbluedot.global in 𝕏

BlueDot provides machine learning-powered infectious disease surveillance and intelligence to enterprises, governments, and healthcare organizations to detect, forecast, and respond to disease outbreaks globally.

AI & Machine LearningDigital HealthGovTechHealthtechToronto, CA

Dr. Kamran Khan(Founder)

Co-investorsHorizons Ventures Golden Ventures

Bresotecbresotec.com

Brightangeltherapeuticsbrightangeltherapeutics.com in 𝕏

Bright Angel Therapeutics is a pre-clinical stage biotechnology company developing small-molecule antifungal therapeutics aimed at drug-resistant and life-threatening invasive fungal infections.

BiotechDeep TechToronto, CA

Leah Cowen(Co-founder & CSO)Luke Whitesell(Co-founder & Consultant)Dominic Jaikaran(President & CEO)in

Co-investorsLumira Ventures

Crowdmarkcrowdmark.com in 𝕏

Crowdmark provides an assessment and grading platform that enables educators to efficiently manage, grade, and provide feedback on student work.

AI & Machine LearningEdTechEnterprise SoftwareSaaSToronto, CA

James Colliander(Co-founder)inJamie Gilgen(Co-founder)inSandra O'Reilly(Co-founder)inMartin Muñoz(Co-founder)inMichelle Caers(Co-founder)in

Dalriadatxdalriadatx.com in

Dalriada is a contract research organization providing integrated small molecule drug discovery services for global biotech and pharmaceutical companies.

BiotechDeep TechMedical DevicesToronto, CA

Diana(Co-founder and Chief Executive Officer)Patrick(Co-founder and Chief Scientific Director)

Co-investorsMedicxi

Damonapharmadamonapharma.com in

Damona develops precision neuromedicines aimed at treating cognitive deficits associated with neurodegenerative and psychiatric disorders such as Alzheimer's disease, depression, and schizophrenia.

BiotechDeep TechDigital HealthHealthtechMedical Devices

Co-investorsAngelini Ventures Lumira Ventures Noetic

Ebt Medicalebtmedical.com in 𝕏

EBT Medical develops neuromodulation technologies targeting the Saphenous nerve to treat pelvic health disorders, particularly overactive bladder.

BiotechMedical Devices

Paul Yoo(Co-founder, President & Chief Scientific Officer)inSasha John(Co-founder and Chief Innovation Officer)inKeith R Carlton(Chief Executive Officer)in

Co-investorsSV Health Investors Genesys Capital

Fibrocortherapeuticsfibrocortherapeutics.com

Flybitsflybits.com in 𝕏

Flybits offers a data exchange platform that digitally connects small businesses to banks' customer networks, enabling personalized merchant offers and enhanced customer engagement throughout the card lifecycle.

AI & Machine LearningData & InfrastructureEnterprise SoftwareFintechMarketing TechToronto, CA

Hossein Rahnama(Founder & CEO)

Co-investorsTD Bank Bosch Ventures Point72 Ventures Robert Bosch Venture Capital Venture Ontario Reinventure Group

Forbiusforbius.com

Co-investorsLumira Ventures

Greymatterneurosciencesgreymatterneurosciences.com in 𝕏

Grey Matter Neurosciences develops transcranial focused ultrasound systems combined with drug therapies to treat mood and cognitive disorders in older adults, with an initial focus on non-invasive neuromodulation outside hospital settings.

BiotechDeep TechDigital HealthHealthtechMedical DevicesToronto, CA

Dr. Jeffrey Coull

Hdaxtxhdaxtx.com

HDAX is a drug-discovery company developing selective small-molecule therapeutics using a proprietary 2-site binding mechanism, starting with the HDAC6 target for neurology, cardiometabolic, and other diseases.

BiotechDeep Tech

Hippocamerahippocamera.com

Hypercarehypercare.com in 𝕏

Hypercare is a HIPAA and PHIPA compliant clinical communication platform that provides secure messaging, real-time on-call scheduling, pager replacement, code team activation, and a centralized contact directory.

Digital HealthHealthtechSaaS

Albert Tai(Founder)in

Co-investorsFoothill Ventures Nina Capital Wavemaker Three-Sixty Health

InventoRRinventorrmd.ca

InventoRR MD develops AbClo, an FDA-licensed non-invasive external traction device used with negative pressure wound therapy to prevent fascial retraction and promote primary fascial closure in open abdomen patients.

HardwareHealthtechMedical Devices

Co-investorsUCeed

Legworkslegworks.com 𝕏

LegWorks develops prosthetic knee devices, specifically the ATK HydraPro, for individuals with lower limb amputations.

HardwareHealthtechMedical Devices

David Green(Co-Founder)Emily Lutyens(Co-Founder)inJan Andrysek(Chief Technology Officer)Brandon Burke(Chief Executive Officer)

Co-investorsHouston Angel Network

Loricacyberloricacyber.com in

Lorica.ai provides a platform for deploying AI models with confidential computing and privacy protections, enabling users from individual developers to enterprises to run secure AI workloads without performance degradation.

AI & Machine LearningCloud ComputingCybersecurity

Mazlitemazlite.com in

Mazlite manufactures the DS10 sensor system that directly images sprays and powders in industrial production environments to enable real-time monitoring, optimization, and process development.

Advanced ManufacturingAI & Machine LearningData & InfrastructureIoTSaaS

Amirreza Amighi(CEO and Co-founder)in

Medlymedly.ca

Medly is a remote patient monitoring program for cardiology care that connects heart-failure patients with specialists through alert-based monitoring.

Digital HealthHealthtechMedical DevicesCanada, CA

Co-investorsAda Ventures Eka Ventures FELIX CAPITAL

Micellaemicellae.com in

Micellae develops drug delivery formulations designed to enhance solubility and potency across multiple dosage forms for pharmaceutical, wellness, and recreational products.

Advanced ManufacturingBiotechDeep TechHealthtechMedical DevicesToronto, CA

Dr. Mehdi Nouraei(Founder and Chief Scientific Officer)Ed(CEO)

Mutuohealthmutuohealth.com in

AutoScribe is an AI-powered digital assistant developed by Mutuo Health Solutions that automates clinical documentation to reduce administrative burden on healthcare providers.

AI & Machine LearningDigital HealthHealthtechMedical DevicesOntario, CA

Dr. Noah Crampton(Investigator, UHN primary care research lead)Geoff Crampton(Directeur général au développement des affaires)in

BoardFrank Rudzicz(Associate Professor, U of T Associate Scientist, St. Michael's Hospital Faculty Member, Vector Institute for AI CIFAR Artificial Intelligence Chair)Muhammad Mamdani(PharmD, U Michigan MPH, Harvard University)

Notchtxnotchtx.com

Co-investorsEcoR1 Capital

Odaiaodaia.ai in

ODAIA offers Marketing Intelligence, a platform for pharmaceutical marketing and sales teams that ties channel-level actions to prescription (Rx) outcomes and coordinates healthcare provider (HCP) engagement across digital and field channels.

AI & Machine LearningDigital HealthHealthtechMarketing TechSaaSSales Tech

Philip Poulidis(Founder)in

Co-investorsGraphite Ventures Monograph Capital Partners Panache Ventures Stand Up Ventures Threshold Ventures Wittington Ventures +5 more

Otosimotosim.com

Pearlinteractivespearlinteractives.com in

Pearl Interactives develops interactive games and experiences for children that combine physical movement, music, and creative learning with technology like mixed reality and touch-free interfaces.

EdTechGamingHealthtech

Phenomic AIphenomic.ai in

Phenomic AI is a biotech company developing therapies for solid tumors using a machine-learning-powered transcriptomics platform that analyzes single-cell RNA data to identify drug targets and understand tumor biology.

AI & Machine LearningBiotechDeep TechToronto, CA

Sam Cooper(Co-founder & CTO)inOren Kraus(Co-founder)in

Co-investorsCantos Ventures AV8 Ventures CTI Life Sciences Fund L.P.Garage Capital Hemi Ventures, Llc Hike Ventures +1 more

PhenoTipsphenotips.com in 𝕏

PhenoTips develops software tools for genomic care that enable patients, doctors, and researchers to collaborate on diagnosis and treatment of genetic conditions.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesSaaSToronto, CA

Pawel Buczkowicz(Chief Operating Officer)in

Co-investorsOntario Centre of Innovation Ontario Centre of Innovation programs Thin Air Labs GreenSky Ventures

Phycusphycusbio.com

Phycus Bio produces Purolic Acid™, a biobased glycolic acid made through fermentation using renewable, FSC-certified wood feedstock for cosmetic, personal care, adhesive, coating, and polymer applications.

BiotechCleantechNew Materials

Co-investorsCircular Innovation Fund Cycle Capital

QD Solarqdsolarinc.com

Qubridgequbridge.io in

Quantum Bridge develops quantum-safe communication technology to protect internet communications against classical and quantum threats, working on quantum entanglement generation and quantum repeaters.

CybersecurityDeep TechQuantum ComputingToronto, CA

Mattia Montagna(CEO & Co-founder)inHoi-Kwong Lo(CSO & Co-founder)in

Co-investorsGood News Ventures Primo Ventures

Qurcanqurcan.com

Qurcan develops veterinary pharmaceutical technology, with leadership holding advanced degrees in veterinary medicine, pharmaceutical sciences, and business development.

BiotechDeep TechHealthtechMedical DevicesCambridge, US

Mohammad Ali Amini(Chief Executive Officer)inShirley Wu(Chief Scientific Officer)John Reid(Chief Business Officer)

Co-investorsFACIT (Fight Against Cancer Innovation Trust)

Radialisradialis.com

Radialis develops the Radialis PET Imager, an organ-targeted positron emission tomography system for high-resolution medical imaging of specific tissues and organs.

Deep TechHealthtechMedical Devices

Alla ReznikAndrew DeanCarmel Shields

BoardWayne Schnarr

Co-investorsFACIT (Fight Against Cancer Innovation Trust)

Radiant Biotherapeuticsradiantbio.com inAug 2024

Radiant Biotherapeutics develops a platform of therapeutic molecules called Multabodies that engage multiple disease targets simultaneously within a single engineered protein to treat cancer and infectious diseases.

BiotechMedical Devices

Arthur Fratamico(Executive Officer, Promoter)Deborah Geraghty, Ph.D.(President and Chief Executive Officer)

Co-investorsFACIT (Fight Against Cancer Innovation Trust)Bill & Melinda Gates Foundation

Reeddireeddi.com in 𝕏

Reeddi provides affordable clean energy solutions and equipment rental services to underserved communities across Africa.

B2B MarketplacesCleantechClimate TechEnergyImpact & Social GoodNigeria, NG

Structurastructura.bio in

Structura Biotechnology develops computational software and methods that scale cryo-EM structure determination for drug discovery and life sciences research.

AI & Machine LearningBiotechDeep Tech

Tabiattabiat.care

Tabiat provides a dedicated nursing team that monitors patients continuously and coordinates care in partnership with healthcare providers, particularly for chronic conditions like COPD.

AI & Machine LearningDigital HealthHealthtechMedical Devices

Trendmdtrendmd.com

Co-investorsFuel Capital

Vasomunevasomune.com

Vasomune is a clinical-stage biotech company developing therapeutic treatments for vascular and immune-related diseases.

BiotechDigital HealthMedical DevicesToronto, CA

Harold Kim(Co-founder)inBrian E. Jahns(Chief Executive Officer)in

Vitalhubvitalhub.com in

VitalHub provides digital health software solutions to hospitals, health systems, and human service providers to enhance care coordination, operational efficiency, and patient engagement.

Digital HealthEnterprise SoftwareGovTechHealthtechSaaSToronto, CA

Zucarazucara.ca

Zucara Therapeutics is a biotech company developing a once-daily therapeutic intended to prevent hypoglycemia (low blood sugar) in people with diabetes.

BiotechDigital HealthHealthtech

Co-investorsJDRF T1D Fund

Portfolio news

latest coverage across their companies

Vitalhub: A Better Business At A Much Better Valuation (VHI:CA) | Seeking Alpha

Vitalhub · seekingalpha.com · Aug 31, 2026

Medly AI Raises €6.89M Seed To Expand AI Tutoring Across UK And International Markets - Teknowire

Medly · teknowire.com · Aug 21, 2026

University of Toronto Entrepreneurship | U of T Startup PhenoTips, Health Institutions Launch National AI Initiative to Solve Bottleneck in Genomic Medicine - University of Toronto Entrepreneurship

PhenoTips · entrepreneurs.utoronto.ca · Apr 7, 2026

Sidley Represents Radiant Biotherapeutics in US$35M Series A Financing | News | Sidley Austin LLP

Radiant Biotherapeutics · sidley.com · Nov 25, 2025

7D Surgical System - Southcoast Health

7D Surgical · southcoast.org · Aug 11, 2025

Frequently asked questions

How many investments has Toronto Innovation Acceleration Partners made?: Toronto Innovation Acceleration Partners has 45 tracked investments.
What stage does Toronto Innovation Acceleration Partners invest at?: Toronto Innovation Acceleration Partners invests at the Pre-Seed, Seed stages.
What sectors does Toronto Innovation Acceleration Partners focus on?: Toronto Innovation Acceleration Partners focuses on Biotech, Digital Health, Healthtech, Medical Devices.
Where is Toronto Innovation Acceleration Partners located?: Toronto Innovation Acceleration Partners is headquartered in Toronto, CA.
Who does Toronto Innovation Acceleration Partners co-invest with?: Toronto Innovation Acceleration Partners most often shares deals with Lumira Ventures, FACIT (Fight Against Cancer Innovation Trust), Stand Up Ventures, among 36 tracked co-investors.

Similar investors

Amadeus Capital Partners

Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.

$50K – $12.7M

Kleiner Perkins

Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.

$500K – $15M

Arboretum Ventures

Arboretum Ventures is a Midwest-based healthcare venture capital firm that invests in early-stage healthcare startups across medical devices, life science tools and diagnostics, tech-enabled care delivery, and pharma adjacencies.

$5M – $15M

Epidarex Capital

Epidarex Capital is a transatlantic venture capital firm focused on early-stage life science companies, backing founders building businesses in emerging innovation hubs.

$2.5M – $6.3M

Illumina Ventures

Illumina Ventures is a venture investor focused on genomics and precision health, aiming to advance innovation and impact in human health.

Featured in lists

Investors & VC Firms in North America Seed Investors & VC Firms Pre-Seed Investors & VC Firms Seed Investors & VC Firms in North America Healthtech Investors & VC Firms Pre-Seed Investors & VC Firms in North America Healthtech Seed Investors & VC Firms Healthtech Investors & VC Firms in North America Biotech Investors & VC Firms Biotech Seed Investors & VC Firms Healthtech Pre-Seed Investors & VC Firms Medical Devices Investors & VC Firms